Literature DB >> 8161676

Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis.

E M Witteman1, W P Hopman, M C Becx, R W De Koning, G N Tytgat, A J Janssen, J B Jansen.   

Abstract

Thirty-three dyspeptic patients with colonization of Helicobacter pylori in the gastric antrum were treated with tripotassium dicitrate bismuthate 120 mg q.d.s. for 28 days and metronidazole 250 mg q.d.s. for 10 days starting on day 19. Five weeks after cessation of this treatment regimen H. pylori was eradicated in 23 patients. In 8 of the remaining 10 patients, H. pylori had become resistant to metronidazole. In this study resistance was significantly associated with smoking habits, but not with age, bacterial load, gastritis score or alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8161676     DOI: 10.1111/j.1365-2036.1993.tb00151.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  Gastroenterology--I: Gastroduodenal disease and Helicobacter pylori.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

2.  Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Authors:  P Moayyedi; D M Chalmers; A T Axon
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

Review 3.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 4.  Helicobacter pylori.

Authors:  B E Dunn; H Cohen; M J Blaser
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

5.  Effect of Helicobacter pylori eradication on peptic ulcer healing.

Authors:  H J O'Connor; C Kanduru; A S Bhutta; J M Meehan; K M Feeley; K Cunnane
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

6.  Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori.

Authors:  E M Witteman; M Mravunac; M J Becx; W P Hopman; J S Verschoor; G N Tytgat; R W de Koning
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.